Loading...
Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agents
Plasma cell leukemia (PCL) is a rare hematologic malignancy with aggressive clinical and biologic features. Data regarding its prognosis with the use of the novel agents, i.e., the immunomodulatory drugs thalidomide and lenalidomide, and the proteasome inhibitor bortezomib, are limited. We retrospec...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
PAGEPress Publications
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3475946/ https://ncbi.nlm.nih.gov/pubmed/23087795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/rt.2012.e39 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|